Stockscreener 앱 받기
1.56
0.64%
-0.01
시간 외 거래:
1.64
0.08
+5.13%
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Why Medicus Pharma Ltd. (N460) stock stays undervaluedPortfolio Performance Report & Safe Investment Capital Preservation Plans - ulpravda.ru
Why retail investors pile into Medicus Pharma Ltd. Equity Warrant stockTrade Exit Summary & Technical Entry and Exit Tips - ulpravda.ru
Can Medicus Pharma Ltd. stock double in next 5 years2025 Analyst Calls & Verified Trade Idea Suggestions - ulpravda.ru
Is Medicus Pharma Ltd. Equity Warrant stock positioned for long term growth2025 Geopolitical Influence & Technical Pattern Recognition Alerts - ulpravda.ru
Will Medicus Pharma Ltd. Equity Warrant stock see PE expansionRate Cut & Weekly Stock Breakout Alerts - ulpravda.ru
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - The Providence Journal
Will Medicus Pharma Ltd. stock deliver better than expected guidanceGeopolitical Risk Analysis & Turn Data into Profits With Our Strategies - ulpravda.ru
How supply chain issues affect Medicus Pharma Ltd. stockRelative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy” - ulpravda.ru
Why Medicus Pharma Ltd. stock could see breakout soonResistance Zone Identification & Small Budget Investment Tips - ulpravda.ru
2026 world cup world class players analysis: Will Medicus Pharma Ltd. Equity Warrant stock benefit from green energy trends2026 world cup usa national team quarterfinals key players low block defense expert forecast expert opinion - ulpravda.ru
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Central New Jersey News
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025FDL Reporter | The Reporter - fdlreporter.com
Medicus Pharma to present phase 2 data at Biotech Showcase 2026 - Investing.com Nigeria
2026 world cup analysis guide: Why Medicus Pharma Ltd. stock could benefit from AI revolution2026 world cup usa national team group stage top scorers transition play tactical prediction guide - ulpravda.ru
Medicus Pharma enters non-binding LOI with Reliant AI - MSN
Medicus Pharma ramps up partnering push as Phase 2 SkinJect data nears - MSN
Medicus Pharma to highlight multiple Phase 2 catalysts at Biotech Showcase 2026 - Proactive financial news
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears - TipRanks
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates - The Manila Times
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as - GlobeNewswire
Setup Watch: Can Medicus Pharma Ltd stock double in next 5 yearsWeekly Earnings Recap & Reliable Momentum Entry Alerts - moha.gov.vn
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights - Victorville Daily Press
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome - The Coloradoan
Dated alerts on Medicus Pharma withdrawn - marketscreener.com
What drives Medicus Pharma Ltd stock priceResistance Breakout Alerts & Test Our Stock Screener — Free Forever - earlytimes.in
Medicus Pharma enters equity distribution agreement for up to $15.3 million By Investing.com - Investing.com Australia
Medicus Pharma enters equity distribution agreement for up to $15.3 million - Investing.com Nigeria
Medicus Pharma Launches At-the-Market Equity Offering Program - TipRanks
Medicus Pharma Signs Equity Distribution Agreement With Maxim Group and Yorkville Securities - TradingView — Track All Markets
Medicus Pharma to offer securities worth up to $100 millionSEC filing - MarketScreener
Medicus Pharma launches at-the-market equity offering program - MSN
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Lubbock Avalanche-Journal
Can Medicus Pharma Ltd stock double in next 5 yearsPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - moha.gov.vn
Medicus Pharma teams with Reliant AI for study push – ICYMI - Proactive financial news
Medicus Pharma’s warrant inducement agreement announced - MSN
Medicus Pharma taps Reliant AI for data-driven Teverelix clinical development - MSN
Medicus Pharma appoints new CFO - MSN
Reliant AI Partners With Medicus Pharma to Apply Generative AI to Prostate Cancer Clinical Trials - TipRanks
0.50%
0.04%
자본화:
|
볼륨(24시간):